Beneficial effects of targeting CCR5 in allograft recipients

Transplantation

Volumn 72, Issue 7, 2001, Pages 1199-1205

  Gao, Wei ^a   Faia, Kerrie L ^a   Csizmadia, Vilmos ^a   Smiley, Stephen T ^a   Soler, Dulce ^a   King, Jennifer A ^a   Danoff, Theodore M ^b   Hancock, Wayne W ^a,c  

^a MILLENNIUM PHARMACEUTICALS INC   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CYCLOSPORIN A; HLA ANTIGEN CLASS 2; LIGAND; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CCR5; NEUTRALIZING ANTIBODY; RANTES; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASE MISPAIRING; BINDING AFFINITY; CELL INFILTRATION; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE TARGETING; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; IMMUNOPOTENTIATION; LIGAND BINDING; MACROPHAGE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MONONUCLEAR CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

EID: 0035886302     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200110150-00003     Document Type: Article

References (22)

1. Chemokines and their receptors in allograft rejection
2. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection
3. Requirement of the chemokine receptor CXCR3 for acute allograft rejection
4. A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection
5. International union of pharmacology. XXII. Nomenclature for chemokine receptors
6. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor
7. Role of C-C chemokine receptor 5 in organ-specific and innate immunity to cryptococcus neoformans
8. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils
9. Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide
10. Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis
11. Requirement of MIP-1 alpha for an inflammatory response to viral infection
12. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
13. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes
14. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: Blocking monocyte arrest and recruitment
15. Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFKB: Implications for tolerance induction
16. Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: The role of cytokines
17. Interferon-gamma increases expression of chemokine receptors CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells
18. Synthesis of the CC-chemokines MIP-1α, MIP-1β, and RANTES is associated with a type 1 immune response
19. Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: Lack of CC chemokine receptor 5 expression results in a NK1.1(+) lymphocyte-associated Th2-type immune response in the intestine
20. The role of the CC chemokine, RANTES, in acute lung allograft rejection
21. Expression of chemokines and chemokine receptors during human renal transplant rejection
22. CC chemokine receptor 5 and renal-transplant survival